You are here: Home » News-CM » Companies » Results
Business Standard

Marksans Pharma consolidated net profit rises 45.56% in the December 2018 quarter

Capital Market 

Sales rise 13.71% to Rs 248.37 crore

Net profit of rose 45.56% to Rs 24.41 crore in the quarter ended December 2018 as against Rs 16.77 crore during the previous quarter ended December 2017. Sales rose 13.71% to Rs 248.37 crore in the quarter ended December 2018 as against Rs 218.43 crore during the previous quarter ended December 2017. ParticularsQuarter EndedDec. 2018Dec. 2017% Var.Sales248.37218.43 14 OPM %14.5713.21 -PBDT34.5927.47 26 PBT29.5521.25 39 NP24.4116.77 46

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Fri, February 08 2019. 16:57 IST
RECOMMENDED FOR YOU
RECOMMENDED FOR YOU